The critical role of prescription management in a peritoneal dialysis program

  • Rosalie Villano
  • Teresa Dunham
  • Salim Mujais
Part of the Developments in Nephrology book series (DINE, volume 39)


Prescription management for patients on renal replacement therapy requires consideration of a wide range of interrelated conditions including dialysis therapy, medications for co-morbid conditions and nutrition. Optimal outcomes cannot be achieved by focusing on solute clearances alone because outcomes are dependent on a constellation of factors related to control of the patient’s disease. Hence, the adequacy of dialysis involves attention to controling co-morbid conditions as well as correction of the consequences of renal failure. Table 22.1 contains a partial list of the components of adequacy in renal replacement therapy. While dialysis addresses many of these components, additional measures are necessary to attain optimal outcomes. Blood pressure control, improved anemia, and better calcium-phosphate metabolism are achievable through adequate dialysis prescription, but additional antihypertensive therapy, erythropoietin administration and increased vitamin D intake are essential for optimal care. Thus, while the present chapter focuses on the elements of dialysis prescription management, the recommendations discussed herein must always be taken in the context of overall patient management.


Peritoneal Dialysis Residual Renal Function Subjective Global Assessment Peritoneal Membrane Automate Peritoneal Dialysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ et al. Recommended clinical practices for maximising peritoneal dialysis clearances. Perit Dial Int 1996; 16:448–56.PubMedGoogle Scholar
  2. 3.
    Burkhart JM, Schreiber M, Korbet SM, Churchill DN, Hamburger RJ, Moran J et al. Solute clearance approach to adequacy of peritoneal dialysis. Perit Dial Int 1996; 16:457–70.Google Scholar
  3. 5.
    DuBois D and DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1961; 17:863–71.Google Scholar
  4. 6.
    Churchill DN, Taylor DW and Keshaviah PK. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes, Canada-USA (CANU-SA) peritoneal dialysis study group. J Am Soc Naphrol 1996; 7:198–207.Google Scholar
  5. 7.
    Twardowski ZJ, Nolph KD, Khanna R et al. Peritoneal equilibration test. Petit Dial Bull 1987; 7:138–47.Google Scholar
  6. 8.
    Durand P, Chanliau J, Gamberoni J, Hestin D and Kessler M. Measurement of hydrostatic intraperitoneal pressure: a necessary routine test in peritoneal dialysis Perit Dial Int 1996: 16:S84–7.Google Scholar
  7. 9.
    Piraiao B, Bernardini J, Sarkar S, Johnsion J and Fried L, JI, exchange volumes are tolerated by most PD patients. Perit Dial Int 1998; 18:S22.Google Scholar
  8. 10.
    Wang T, Heimbürgar O, Wamewski J, Bergström J and Lindhoim B. Time dependence of solute removal during a single exchange. Adv Perit Dial 1997; 13: 23–8.PubMedGoogle Scholar
  9. 11.
    Wang T, Waniewski J, Heimburger O, Werynski A and Lindholm B. A quantitative analysis of sodium transport and removal during peritoneal dialysis. Kidney Int 1997, 52:1609–16.PubMedCrossRefGoogle Scholar
  10. 32.
    Mistry CD, Gokai R, Peers E and the MIDAS study group. A. randomized rnulticenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. Kidney Int 1994; 46:496–503.PubMedCrossRefGoogle Scholar
  11. 13.
    Vonesh E, Burkart J, McMurray S and Williams P. Peritoneal dialysis kinetic modeling: validation in a multicenter clinical study. Perit Dial Int 1996; 16:471–81.PubMedGoogle Scholar
  12. 14.
    Jones MR. Etiology of severe malnutrition: results of an international cross-sectional study in continuous ambulatory peritoneal dialysis patients. Am J Kidney Dis 1994; 23:412–20.PubMedGoogle Scholar
  13. 15.
    Kopple JD and Blumenkrantz MJ. Nutritional requirements for patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1983; 24:S295–302.Google Scholar
  14. 16.
    Bergström J et al. Protein and energy intake, nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 1993; 44:1048–57.PubMedCrossRefGoogle Scholar
  15. 17.
    Enia G, Sicuso C, Alati G and Zoccali C. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transp 1993; 8:1094–8.Google Scholar
  16. 18.
    Oreopoulos DG, Anderson GH, Bergström J et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17:462–71.PubMedGoogle Scholar
  17. 19.
    Wilkie ME. Icodextrin 7.5% dialysate solution in patients with ultrafiltration failure: extension of CAPD technique survival. Perit Dial Int 1997; 17:84–6.PubMedGoogle Scholar
  18. 20.
    Tebeau J, Moran J, Vonesh E and Harter M. Improvements in delivered dose utilizing a prescription management process. Perit Dial Int 1998; 18:S23.Google Scholar

Copyright information

© Kluwer Academic Publishers 1999

Authors and Affiliations

  • Rosalie Villano
  • Teresa Dunham
  • Salim Mujais

There are no affiliations available

Personalised recommendations